A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)

计划入组 98 人 · 首次发布于 2007 年 8 月 15 日

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer

计划入组 30 人 · 首次发布于 2017 年 11 月 7 日

Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma

计划入组 126 人 · 首次发布于 2008 年 6 月 2 日

JAB-26766

PARP/MEK dual inhibitors (MD Anderson)

Ribose-1-Phosphate

C₅H₁₁O₈P

NHI-1

United States

POLY MEDICURE LIMITED

India

Poly Pharmaceuticals Inc

United States

Endometrial Cancer Clinical Trial Landscape Shows Increasing Global Activity

Saruparib Shows Promise in HRR-Deficient Breast Cancer

BRCA2 Mechanism Reveals Why PARP Inhibitors Work in Only Some Cancer Patients